Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Ranbaxy Laboratories, the leading Indian pharmaceutical firm, has been in the eye of a storm over allegations by US federal investigators about the manufacturing practices followed at its Paonta Sahib plant in Himachal Pradesh. The plant has what is considered the most prestigious certificate in the world for such an …
Pb Jayakumar / Mumbai July 18, 2008, 0:41 IST Indoco Remedies, a leading Mumbai-based generic drug maker, is planning to launch about 40 drugs in the domestic market within a year. Also, they are forming a new marketing division targeting gynaecologists and paediatricians. Most drug launches will be in its …
Pb Jayakumar / Mumbai July 18, 2008, 0:40 IST US-based Abbot Laboratories has filed a suit against Dr Reddy's Laboratories for infringing the patent of Depakote ER, an anti-seizure or epilepsy drug with sales of over $1.48 billion (more than s 6,000 crore) in the American market. The lawsuit was …
After rising 15 per cent Wednesday, the Ranbaxy stock resumed its downward journey on reports in the US media that a US Congressional Committee will examine Ranbaxy's drug approvals in the US and potential violations of manufacturing regulations. The committee will also scrutinise the US drug regulator Food and Drug …
AUS Congressional Committee is launching an investigation into whether US Food and Drug Administration (FDA) was lenient in allowing Ranbaxy to sell new drugs in the US market when it was still investigating discrepancies at the Indian pharma major's manufacturing facility in India. The committee will also examine whether the …
The Ranbaxy sale to Daiichi Sankyo could herald a new phase in the evolution of the Indain pharmaceutical industry. In order to cope in a world after the agreement on Trade-related Aspects of Intellectual Property Rights came into force, some of the larger Indian firms pursued the two strategies of …
New York: Researchers have taken a big step closer to a cure for the most common strain of avian influenza, or "bird flu,' the potential pandemic that has claimed more than 200 lives and infected nearly 400 people in 14 countries since it was identified in 2003. Scientists at the …
THE hurdles that pharmaceutical companies face in accessing global markets may now ease. The drug regulator's office is likely to extend the tenure of export licence and other approvals from one year to at least three years. The move is expected to help many pharma companies that export huge quantities …
Drug-maker filed response in US court yesterday. Under fire in the United States for giving distorted information on the generic drugs it sold, Ranbaxy Laboratories today said that it will file all relevant information within a month after which the legal case initiated against it by the US government will …
Drug Regulatory System In India Has Abysmal Standards And There's No Credible Mechanism To Monitor Adverse Drug Reactions K G Narendranath NEW DELHI IT'S PRESUMPTUOUS to comment on the verity of the US department of justice allegation that Ranbaxy has mixed up bulk drugs procured from approved and unapproved sources, …
An alleged scam involving huge quantities of expired medicines worth lakhs of rupees dumped in a storeroom of the civil hospital, Sohna, has come to light. These medicines supplied by the government were meant to be distributed to patients free of cost. The district health authorities went into tizzy following …
New US rules to free clinical trials of ethics it is alleged that Johnson and Johnson carried out clinical trials of its anti-psychotic drug, Risperdal, in Gujarat three years ago without the informed consent of patients. The study also used placebos despite drugs being available for treatment. Both these actions …
Scientists begin work on vaccine in Port Blair scientists at the Regional Medical Research Centre (rmrc) of Andaman and Nicobar Islands are all set to begin work on developing a vaccine against Chikungunya, a viral infection that killed over 80 people in India in 2006.
BS Reporter / New Delhi July 09, 2008, 0:14 IST Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has increased the prices of 19 imported insulin-based medicines. The decision is in response to requests made by importers Eli Lilly and Pfizer, who wanted an increase in the prices of specific …
V NarayanaMurthi | ENS Vellore THE experimental trials conducted in Vellore district on the new vaccine evolved by the Tamilnadu Veterinary and Animal Sciences University (TANUVAS), to combat the deadly anthrax, have proved to be successful, according to its vice-chancellor Dr P Thangaraju. He was here on Wednesday to visit …
The state government has ayed proposals for setting up three pharmaceutical units with an investment of Rs 275 crore in special economic zones at Indore and Gwalior. The Glenmark group would establish two units - Rs 175 cr - while Teva API India group would set up one over 29 …
Govt Looking At Several Ways To Ensure Availability Of Essential Drugs THERE may be good news for the pharma industry, which has been facing price caps and fighting high input costs. The government is learnt to be considering liberalising the 10% mandatory cap on price hike for drugs outside the …
Khomba Singh NEW DELHI THERE may be good news for the pharma industry, which has been facing price caps and fighting high input costs. The government is learnt to be considering liberalising the 10% mandatory cap on price hike for drugs outside price control. Non-scheduled drugs or drugs outside the …
An Indian company buying a foreign company or a foreign company acquiring an Indian company should not inflate or deflate our pride -Jaskaran Singh Dhami We got puffed up with pride when Lakshmi Mittal made ripples in the business world by buying Arcelor. The tugging of 'Corus' by Tatas added …
